Volume | 91,687 |
|
|||||
News | - | ||||||
Day High | 0.0036 | Low High |
|||||
Day Low | 0.003 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CBD Life Sciences Inc (PK) | CBDL | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.003 | 0.003 | 0.0036 | 0.0036 | 0.00356 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
33 | 91,687 | $ 0.003214 | $ 295 | - | 0.0003 - 0.03 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:54:56 | 500 | $ 0.0036 | USD |
CBD Life Sciences Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 167.42M | 46.51B | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CBD Life Sciences (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBDL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0052 | 0.0052 | 0.003 | 0.003491 | 398,092 | -0.0016 | -30.77% |
1 Month | 0.0062 | 0.02241 | 0.00275 | 0.0051361 | 552,713 | -0.0026 | -41.94% |
3 Months | 0.03 | 0.03 | 0.0003 | 0.0195982 | 7,454,270 | -0.0264 | -88.00% |
6 Months | 0.015 | 0.03 | 0.0003 | 0.0167116 | 7,690,589 | -0.0114 | -76.00% |
1 Year | 0.0003 | 0.03 | 0.0003 | 0.0143759 | 7,123,593 | 0.0033 | 1,100.00% |
3 Years | 0.15 | 0.18 | 0.0003 | 0.0936611 | 120,290,966 | -0.1464 | -97.60% |
5 Years | 4.545 | 20.52 | 0.0003 | 0.3362646 | 120,547,984 | -4.54 | -99.92% |
CBD Life Sciences (PK) Description
CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol 'CBDL'. The Company's main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector. About LBC Bioscience Inc. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesaling a full line of cannabidiol based organic products including CBD drops, pain relief creams, anxiety and sleep supplements, gummies, Cartridge and a full pet line. LBC's products can be viewed and purchased on the company website at www.lbcbioscienceinc.com. |